Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Innovation Sources For Medical Technology Begin Shift To Emerging Markets, But Large Capability Hurdles Remain - PwC Report

This article was originally published in PharmAsia News

Executive Summary

TOKYO - The U.S. has been the main source of medical technology innovation for many years, but the growing economies and technological capabilities of countries like China and India could soon shift the balance. The leading emerging markets are already making headway in becoming innovation leaders, although they will need to overcome large caveats that are stunting the development of innovative technologies

Latest Headlines
See All
UsernamePublicRestriction

Register

SC076245

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel